MOFECON 500MG TABLET

Mofecon 500 mg tablet is an immunosuppressant with an active ingredient named Mycophenolate mofetil. It is part of the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is prescribed to avoid organ rejection in people who have had the organs of a donor (such as heart, kidney and liver transplantation). It is defined as a part of a treatment combination which includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy due to the possibility of miscarriage and congenital disabilities. It is not recommended during pregnancy unless there are other alternatives and the possible advantages outweigh the risks. Women who are pregnant should use the most effective contraception when taking this tablet to stop pregnancies. Live vaccines shouldn’t be administered when a person is taking Mofecon 500 mg Tablet because of the decreased vaccine effectiveness and risk of contracting infection. People taking this drug are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. It is a way to ensure that the medication is eliminated from the body before donating blood.
It is usually advised not to use this medication in case you have an allergy to the drug or other ingredients. Inform your doctor about heart or liver disease before starting the treatment. Since this medication weakens the body’s immune system, it may increase the risk of developing skin cancer. People should take steps to minimize their exposure to sun and the ultraviolet (UV) ultraviolet (UV) light. Contact your physician immediately when you experience any bleeding on the surface, fever or unprovoked tiredness, dizziness or eyes, or skin. Eyes vision impairment, decreased urine output, or seizures following the use of this medication. Mofecon is a 500 mg tablet and an immunosuppressive drug. It can affect the infant’s developing immune system and should not be used when breastfeeding. In certain situations, alternatives to medications that have an improved safety profile for breastfeeding can be thought of as.